Search Results - "Nanavati, Nayan"
-
1
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study
Published in American journal of obstetrics and gynecology (01-09-2002)“…Objective: Selective estrogen receptor modulators are novel compounds that bind to the estrogen receptor and have mixed agonistic and antagonistic activities…”
Get full text
Journal Article -
2
Initial 17β-Estradiol dose for treating vasomotor symptoms
Published in Obstetrics and gynecology (New York. 1953) (01-05-2000)“…Objective: To compare the efficacy of different doses of 17β-estradiol (E2) for relief of vasomotor symptoms in menopausal women. Methods: This was a…”
Get full text
Journal Article -
3
Norethindrone Acetate and Estradiol-Induced Endometrial Hyperplasia
Published in Obstetrics and gynecology (New York. 1953) (01-09-2000)Get full text
Journal Article -
4
Uterine Bleeding in Postmenopausal Women on Continuous Therapy With Estradiol and Norethindrone Acetate
Published in Obstetrics and gynecology (New York. 1953) (01-09-1999)“…OBJECTIVETo investigate the incidence of uterine bleeding during 12 months of treatment with 17β-estradiol (E2) 1 mg, unopposed or in combination with three…”
Get full text
Journal Article -
5
Norethindrone acetate and estradiol-induced endometrial hyperplasia
Published in Obstetrics and gynecology (New York. 1953) (01-09-2000)“…Objective: To identify the lowest effective continuous dose of norethindrone acetate that significantly reduces 12-month incidence of endometrial hyperplasia…”
Get full text
Journal Article -
6
Initial 17β-Estradiol Dose for Treating Vasomotor Symptoms
Published in Obstetrics and gynecology (New York. 1953) (01-05-2000)Get full text
Journal Article -
7
Uterine Bleeding in Postmenopausal Women on Continuous Therapy With Estradiol and Norethindrone Acetate
Published in Obstetrics and gynecology (New York. 1953) (01-09-1999)Get full text
Journal Article -
8
Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate
Published in Obstetrics and gynecology (New York. 1953) (1999)“…Objective: To investigate the incidence of uterine bleeding during 12 months of treatment with 17β-estradiol (E2) 1 mg, unopposed or in combination with three…”
Get full text
Journal Article -
9
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women
Published in Archives of internal medicine (1960) (27-11-2000)“…To evaluate the influence of 2 continuous combined estrogen-progestin replacement products, compared with unopposed estrogen and placebo, on cardiovascular…”
Get more information
Journal Article